FDA approves second cervical cancer vaccine, Cervarix, for preventing HPV in women

Links shared publicly online about this topic.

  • 1,759
    total visits

FDA approves second cervical cancer vaccine, Cervarix, for preventing HPV in women

nydailynews.com

Federal health officials said Wednesday a long-delayed vaccine from GlaxoSmithKline successfully blocks the leading virus that causes cervical cancer in women.

View full resource at nydailynews.com

Tags: Cervical Cancer, Cervical Cancer Prevention, Women's Health, FDA, Vaccine, HPV Vaccine, Cervarix, GlaxoSmithKline

  • Share

Most Recently Shared on September 10, 2009 at 3:34 pm By:

NYDNlifestyle NYDN Lifestyle

FDA backs new HPV vaccine, Cervarix: Federal health officials said Wednesday a long-delayed vaccine from GlaxoSm.. http://bit.ly/30QPTi

3 years ago...

FDA Approves New Vaccine for Prevention of Cervical Cancer

fda.gov — “The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on October 19, 2009 at 4:49 pm By:

Nurse_com Gannett Healthcare Health News

FDA Approves Cervarix Vaccine for Prevention of Cervical Cancer: http://bit.ly/3aQ67b

2 years ago...

Cervarix approved for prevention of HPV-associated cervical cancer - MPR

empr.com — “The FDA has approved Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant, from GlaxoSmithKline) for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and women 10"25 years of age.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 8:55 pm By:

eMPR MPR Medical Publisher

MPR News: Cervarix approved for prevention of HPV-associated cervical cancer: The FDA has approved Cerv.. http://bit.ly/WF8uF

2 years ago...

FDA approves Cervarix human papilloma vaccine as cervical cancer deterrent [Updated] | Booster Shots | Los Angeles Times

latimesblogs.latimes.com — “The food and drug administration today approved cervarix, the vaccine against human papilloma virus (hpv) manufactured by glaxosmithkline, for use in girls and young women ages 10 to 25. an fda adivsory panel recommended approval of the vaccine on sept....View full resource at latimesblogs.latimes.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 4:10 pm By:

LATimeshealth LA Times Health News Health News

FDA approves Cervarix human papilloma vaccine as cervical cancer deterrent http://bit.ly/3NhY9x

2 years ago...

Advertisement